A Study to Evaluate Enfortumab Vedotin in Subjects With Locally Advanced or Metastatic Malignant Solid Tumors (EV-202)
Astellas Pharma Inc
Astellas Pharma Inc
Hoffmann-La Roche
Washington University School of Medicine
Washington University School of Medicine
Seagen Inc.
UNC Lineberger Comprehensive Cancer Center
National Cancer Institute (NCI)
University of California, San Diego
National Cancer Institute (NCI)
Takeda
University of Washington
Stanford University
National Cancer Institute (NCI)
University of Connecticut
Dana-Farber Cancer Institute
Tempus AI
Dartmouth-Hitchcock Medical Center
National Institutes of Health Clinical Center (CC)
Novartis
Johns Hopkins University
NGM Biopharmaceuticals, Inc
University of Oxford